FDA Inspection 1166323 — OmniLife Science
The FDA completed an inspection of OmniLife Science on April 4, 2022 in Raynham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Raynham, MA (United States)